HHS/ASPR Biodefense + Bioterrorism Preparedness News

ASPR

The office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services.

Biodefense Headlines – 31 March 2025

Biosecurity March 31, 2025

This week’s topics include restructuring of ASPR, anti-vaccine leadership at NIH, the UK’s new pathogen priority research targets list, and data on a post-exposure treatment for filoviruses. FEATURED Trump Administration…

ASPR

SIGA Begins Smallpox Drug Shipments to National Stockpile

FDA Approves Raxibacumab to Treat Inhalational Anthrax

Emergent BioSolutions Secures Rights to Pandemic Influenza Vaccine Candidate

Novartis Receives FDA Approval for First Cell-Culture Influenza Vaccine

Hurricane Sandy Impacts Biodefense, CBRN Conferences

NIAID Awards Funding for Non-Needle Anthrax Vaccine

BARDA Exercises Contract Option on Emergent BioSolutions Anthrax Vaccine

Dried Plasma Device for CBRNE Mass Casualty Scenario

New BARDA-Funded Influenza Diagnostic Launched

Cytori to Develop Cell Therapies for Radiation Injury Thermal Burns

Hertfordshire Receives BARDA Award for Mass Casualty Decon Studies

BARDA Announces CBRN Medical Countermeasures Conference

NextBio Awarded $26M for Broad-Spectrum Influenza Phase 2

HHS Announces Pandemic Preparedness Contracts to Top Pharma

Ricin Vaccine Shows Positive Phase 1B Clinical Trial Results

BARDA Seeks Antitoxins for Treatment of Inhalational Anthrax

Army to Award Chemical Warfare Agent Research Contract to BBRI

BARDA Multi-BAA Pre-Proposal Conference for CBRN, Influenza Countermeasures

Emergent Biosolutions, Novartis, Texas A&M to Lead New Biodefense Centers

BARDA CBRN Medical Countermeasures Pre-Proposal Conference

Biodefense Headlines – 31 March 2025